The Food and Drug Administration today issued a final order exempting manufacturers from FDA premarket notification requirements for certain N95 respirators, disposable devices used to protect patients and health care providers from infection. Under a new memorandum of understanding between the FDA and National Institute for Occupational Safety and Health, organizations seeking to market N95 respirators that do not exceed certain criteria need only NIOSH certification. The final order and MOU, effective tomorrow, are intended to streamline regulatory requirements to help ensure adequate supply of the devices during public health emergencies.

Related News Articles

Headline
The Food and Drug Administration recently created an online compendium page of COVID-19 resources for health care professionals. FDA has indicated it will…
Headline
The Food and Drug Administration Monday authorized the emergency use of two new products designed to respond to the COVID-19 ventilator shortage. FDA approved…
Headline
U.S. hospital emergency department visits declined by an estimated 42% between March 29 and April 25 compared to a year ago, while visits for infectious…
Headline
The Center for Medicare and Medicaid Innovation today announced several COVID-19-related modifications to current and future CMMI alternative payment models.…
Headline
The Department of Health and Human Services yesterday said it is providing an additional $250 million to aid health systems’ response to the COVID-19 pandemic…
Headline
Today is the deadline for eligible health care providers to submit their revenue information to the Department of Health and Human Services to potentially…